The role of IL-6 in host defence against infections: immunobiology and clinical implications
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of IL-6 in host defence against infections: immunobiology and clinical implications
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 13, Issue 7, Pages 399-409
Publisher
Springer Nature
Online
2017-06-15
DOI
10.1038/nrrheum.2017.83
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema
- (2016) Saleela M. Ruwanpura et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Heterogeneity of Human CD4+T Cells Against Microbes
- (2016) Federica Sallusto Annual Review of Immunology
- Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in MiceHighlights
- (2016) Alexandros Nicolaou et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- STAT3 signaling in immunity
- (2016) Emily J. Hillmer et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation
- (2016) Neele Schumacher et al. JOURNAL OF IMMUNOLOGY
- Cytokines and T-Cell Homeostasis in HIV Infection
- (2016) Michael L. Freeman et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study
- (2016) Naoki Ishiguro et al. Modern Rheumatology
- Janus Kinase 1 Is Essential for Inflammatory Cytokine Signaling and Mammary Gland Remodeling
- (2016) Kazuhito Sakamoto et al. MOLECULAR AND CELLULAR BIOLOGY
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis
- (2016) Philip J. Mease et al. Arthritis & Rheumatology
- Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments
- (2016) Fenglong Xie et al. Arthritis & Rheumatology
- Insights into Cytokine–Receptor Interactions from Cytokine Engineering
- (2015) Jamie B. Spangler et al. Annual Review of Immunology
- Emerging clinical phenotypes associated with anti-cytokine autoantibodies
- (2015) Thierry Vincent et al. AUTOIMMUNITY REVIEWS
- Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
- (2015) Michael J. Kraakman et al. Cell Metabolism
- Hyper-IgE syndromes
- (2015) Susan Farmand et al. CURRENT OPINION IN HEMATOLOGY
- Interleukin-6: Biology, signaling and strategies of blockade
- (2015) Fred Schaper et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Allergen-induced IL-6 trans-signaling activates γδ T cells to promote type 2 and type 17 airway inflammation
- (2015) Md Ashik Ullah et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Ying and Yang of STAT3 in Human Disease
- (2015) Tiphanie P. Vogel et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial
- (2015) Tsutomu Takeuchi et al. Modern Rheumatology
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- ROUTINE—a prospective, multicentre, non-interventional, observational study to evaluate the safety and effectiveness of intravenous tocilizumab for the treatment of active rheumatoid arthritis in daily practice in Germany
- (2015) Christof Iking-Konert et al. RHEUMATOLOGY
- Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy
- (2015) Huifeng Yun et al. ARTHRITIS CARE & RESEARCH
- Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials
- (2015) Vibeke Strand et al. ARTHRITIS RESEARCH & THERAPY
- The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results From a Multinational, Phase IIb, Randomized, Double-Blind, Placebo/Active-Controlled, Dose-Ra
- (2015) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Innate and Adaptive Immune Regulation During Chronic Viral Infections
- (2015) Elina I. Zuniga et al. Annual Review of Virology
- Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)
- (2014) Clifton O Bingham et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study
- (2014) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy
- (2014) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy
- (2014) Huifeng Yun et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation
- (2014) Ceri A. Fielding et al. IMMUNITY
- C-reactive protein is essential for innate resistance to pneumococcal infection
- (2014) J. Paul Simons et al. IMMUNOLOGY
- Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs
- (2014) Jun Nakamura et al. International Journal of Rheumatic Diseases
- Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-β (TGF-β) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein
- (2014) Steven O'Reilly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis
- (2014) M. A. Nowell et al. JOURNAL OF IMMUNOLOGY
- Masked early symptoms of pneumonia in patients with rheumatoid arthritis during tocilizumab treatment: a report of two cases
- (2014) Hiroshi Fujiwara et al. Modern Rheumatology
- A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B
- (2014) Hideki Tsuboi et al. Modern Rheumatology
- Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
- (2014) Jan Mauer et al. NATURE IMMUNOLOGY
- IL-6 biology: implications for clinical targeting in rheumatic disease
- (2014) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo
- (2014) Helen L. Wright et al. RHEUMATOLOGY
- Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
- (2014) Zsuzsanna H McMahan et al. ARTHRITIS RESEARCH & THERAPY
- Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
- (2014) Meliha C Kapetanovic et al. ARTHRITIS RESEARCH & THERAPY
- IL-6 trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function
- (2014) Jan P. Böttcher et al. Cell Reports
- Neutrophil-Derived Cytokines: Facts Beyond Expression
- (2014) Cristina Tecchio et al. Frontiers in Immunology
- Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
- (2013) Shunsuke Mori et al. ANNALS OF THE RHEUMATIC DISEASES
- Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections
- (2013) Toshihiro Nanki et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 controls susceptibility to helminth infection by impeding Th2 responsiveness and altering the Treg phenotype in vivo
- (2013) Katherine A. Smith et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
- (2013) T. Koike et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
- (2013) Cem Gabay et al. LANCET
- Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab
- (2013) Tomomi Tsuru et al. Modern Rheumatology
- Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
- (2012) Shunsuke Mori et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
- (2012) Vivian P Bykerk et al. ANNALS OF THE RHEUMATIC DISEASES
- HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice
- (2012) J. Suthaus et al. BLOOD
- An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer
- (2012) Christoph Garbers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
- (2012) J. Hoge et al. JOURNAL OF IMMUNOLOGY
- The interleukin 6 pathway and atherosclerosis
- (2012) Jürgen Scheller et al. LANCET
- Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung
- (2012) O Dienz et al. Mucosal Immunology
- Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
- (2011) T. Koike et al. ANNALS OF THE RHEUMATIC DISEASES
- Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
- (2011) Harald Schuett et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
- (2011) Simon A. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms controlling Th17 cytokine expression and host defense
- (2011) Jeremy P. McAleer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Unchanged serum viral load and liver function during tocilizumab treatment in a patient with rheumatoid arthritis and hepatitis C virus infection
- (2011) Takao Nagashima et al. RHEUMATOLOGY INTERNATIONAL
- Late Interleukin-6 Escalates T Follicular Helper Cell Responses and Controls a Chronic Viral Infection
- (2011) J. A. Harker et al. SCIENCE
- Integrated safety in tocilizumab clinical trials
- (2011) Michael H Schiff et al. ARTHRITIS RESEARCH & THERAPY
- STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction
- (2010) H. Nguyen-Jackson et al. BLOOD
- Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action
- (2010) F. Thomas Wunderlich et al. Cell Metabolism
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
- (2010) Athena Chalaris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function
- (2010) Leif E. Sander et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor
- (2010) M. M. McFarland-Mancini et al. JOURNAL OF IMMUNOLOGY
- Castleman's disease—a two compartment model of HHV8 infection
- (2010) Klaus-Martin Schulte et al. Nature Reviews Clinical Oncology
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection
- (2009) Marianna Hösel et al. HEPATOLOGY
- IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens
- (2009) W. A. Neveu et al. JOURNAL OF IMMUNOLOGY
- Unraveling Viral Interleukin-6 Binding to gp130 and Activation of STAT-Signaling Pathways Independently of the Interleukin-6 Receptor
- (2009) N. Adam et al. JOURNAL OF VIROLOGY
- Long-term tocilizumab therapy in a patient with rheumatoid arthritis and chronic hepatitis B
- (2008) T. Nagashima et al. RHEUMATOLOGY
- Interleukin-6 Is Crucial for Recall of Influenza-Specific Memory CD4+ T Cells
- (2008) Maria Paula Longhi et al. PLoS Pathogens
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now